Page last updated: 2024-09-04

birb 796 and angiotensin ii, des-phe(8)-

birb 796 has been researched along with angiotensin ii, des-phe(8)- in 1 studies

Compound Research Comparison

Studies (birb 796)	Trials (birb 796)	Recent Studies (post-2010) (birb 796)	Studies (angiotensin ii, des-phe(8)-)	Trials (angiotensin ii, des-phe(8)-)	Recent Studies (post-2010) (angiotensin ii, des-phe(8)-)
137	5	80	1,533	21	995

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clasen, T; Fähling, M; Ishak, B; Kojda, G; Mende, S; Patzak, A; Potthoff, SA; Rump, LC; Sivritas, SH; Stamer, S; Stegbauer, J; Suvorava, T; Thieme, M	1

Other Studies

1 other study(ies) available for birb 796 and angiotensin ii, des-phe(8)-

Article	Year
Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:2 Topics: Angiotensin I; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Pressure; Disease Models, Animal; Female; Hypertension, Renal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyrazoles; Receptors, G-Protein-Coupled; Renal Circulation; Vascular Resistance	2014

Article

Year

Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.

Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:2

Topics: Angiotensin I; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Pressure; Disease Models, Animal; Female; Hypertension, Renal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyrazoles; Receptors, G-Protein-Coupled; Renal Circulation; Vascular Resistance

2014